š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
This study aim is to evaluate the additional effect of eicosapentaenoic aci...
Status
Unknown
Location
Kobe University Graduate School of Medicine, Department of Cardiology
Start Date
2018-09-17
Trial ID
NCT03657758
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047501
Treatments Being Tested
AMR101 (icosapent ethyl \[ethyl-EPA\]) is a highly purified ethyl ester of ...
Status
Completed
Location
Amarin Investigational Site
Start Date
2011-11
Trial ID
NCT01492361
Treatments Being Tested
This study aim to evaluate whether intensive lipid lowering therapy may imp...
Status
Completed
Location
Multiple Locations
Start Date
2013-07-26
Trial ID
NCT03192579
Treatments Being Tested
The primary objective is to determine the efficacy of AMR101 (ethyl icosape...
Status
Completed
Location
Amarin Investigational Site
Start Date
2009-12
Trial ID
NCT01047683
Treatments Being Tested
This study is intended to evaluate the potential 2-way reciprocal interacti...
Status
Completed
Location
Celerion
Start Date
2013-09
Trial ID
NCT02859129